Inflation rebates to reduce Medicare payment for 27 Part B drugs

This April through June under the Inflation Reduction Act, Medicare will reduce the coinsurance amount for 27 Part B prescription drugs from 20% to somewhere between 10% and 19.9%, depending on the drug, the Centers for Medicare & Medicaid Services announced today.
The IRA requires drug companies to pay rebates to Medicare when prices for certain single-source and biosimilar prescription drugs covered under Part B increase faster than the rate of inflation. These 27 drugs are among the first rebatable drugs under the law. Part B drugs impacted by a coinsurance adjustment may change quarterly. For more information, see the CMS fact sheet.
Related News Articles
Headline
As millions of people are losing their Medicaid coverage as a result of the redetermination process, hospitals and health systems are seeing substantial…
Blog
More than 90 million people had access to health care through Medicaid’s pandemic-related continuous coverage provisions. That coverage ended March 31, 2023,…
Headline
The Food and Drug Administration will accept comments through Nov. 17 on draft guidance for labeling proposed biosimilar and interchangeable biosimilar…
Headline
This October through December under the Inflation Reduction Act, Medicare will reduce the beneficiary coinsurance amount for 34 Part B prescription drugs …
Headline
A new Centers for Medicare & Medicaid Services fact sheet reviews how the agency selected the first 10 Part D drugs to include in the Medicare Drug Price…
Headline
Health and Human Services Secretary Xavier Becerra last week declared a public health emergency for Florida in response to Hurricane Idalia and waived or…